Tag Archives: January.ai

Novo QW Insulin Icodec Ph2 Data; Lilly Pump Feasibility Data; New Dasiglucagon Data; January.ai Glucose Prediction Algorithm; Key Press Releases (June 14)

Today, four diabetes-related news items were observed: Novo presented Ph2 QW insulin icodec data in T2DM, Lilly presented feasibility data for its automated insulin delivery system, Zealand presented additional dasiglucagon data (including pediatrics), and January.ai showcased its new glucose prediction algorithm. Below, FENIX provides context and analysis for the announcements.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.